InvestorsHub Logo
Followers 25
Posts 1230
Boards Moderated 0
Alias Born 12/11/2008

Re: Witte44 post# 91492

Tuesday, 09/15/2020 10:30:45 AM

Tuesday, September 15, 2020 10:30:45 AM

Post# of 97081
What ever happened to DECN's 13 million line of credit?

March 20, 2020
DECN to Finance 2Q 2020 Roll Out of its GenViro! Covid-19 “Rapid” Kits Using Non-Dilutive Debt Financing Totaling $13 Million Acquired in Near 0% Rate Environment

"The $13 million we seek, split by need, will carry us for the remainder of 2020."
https://apnews.com/ACCESSWIRE/026672c9f71fbb92a245aaaa08f269e4

DECN Enters into an Additional 6 Month $300,000 Promissory Note With Major Current Investor to Further Assist Launch of Genviro Swift Kits for the Detection of the Covid-19 Virus

LOS ANGELES, CA / ACCESSWIRE / September 15, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. the manufacturers and design specifiers for the :10.5 GenViro! Professional Swift Kit for testing Covid-19 testing, today announced that it has entered into agreement with a major investor for a six month 8% Promissory Note. Principal and interest will be due and payable in six months.
Separately the company has announced that six existing Promissory Notes with the same investor have been extended for an additional four (4) months each. The new Note and the previous Notes are for payment of principal and interest only. No conversion rights are included. The company had previously announced that the GenViro! Swift kit will be available for sale on September 26, 2020 in select International venues.

https://www.accesswire.com/606026/DECN-Enters-into-an-Additional-6-Month-300000-Promissory-Note-With-Major-Current-Investor-to-Further-Assist-Launch-of-Genviro-Swift-Kits-for-the-Detection-of-the-Covid-19-Virus